Trial Profile
Co-administration of sub therapeutic concentrations of posaconazole among adult patients with hematological malignancies who received posaconazole tablets for prophylaxis of IFIs
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Aug 2018
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Mycoses
- Focus Therapeutic Use
- 28 Aug 2018 New trial record
- 05 Jul 2018 Results published in the British Journal of Clinical Pharmacology